2/28/2025Duality Biologics Withdraws Hong Kong IPO Plans Amidst Strategic Partn...

2/28/2025NMPA Approves Multiple Drugs for Cancer, Cardiovascular, and Liver Dis...

2/28/2025CDE Seeks Public Feedback on "SPARK Initiative" to Boost Pediatric Onc...

2/28/2025Recent Executive Moves

2/28/2025Henlius Initiates Phase 1b/2 Trial for PD-L1 ADC HLX43 in Solid Tumors

2/28/2025SciClone Secures Rights to Eisai's Tasurgratinib for Greater China

2/28/2025China's Tech Giants Look to Healthcare (The Wire China)

2/28/2025Pace, Price of China Licensing Deals Continues to Rise (BioCentury)

2/27/2025Fail to Launch: Affordable Gene Therapy from China - A Realty Within R...

2/27/2025IVIEW Thera Reports Positive Phase 1/2 Results for IVW-1001 Ophthalmic...

2/27/2025HBM Alpha Enters License Deal to Advance Novel Endocrine Therapies

2/27/2025Henlius Registers Phase 3 Trials for Keytruda and Yervoy Biosimilars

2/27/2025Biokin (SystImmune) Initiates First Autoimmune Clinical Trial for Tetr...

2/27/2025Akeso Initiates First-in-Human Phase 1 Trial for HER3-Targeting ADC AK...

2/27/2025Novartis' NDA for BTK Inhibitor Remibrutinib Accepted by NMPA

2/27/2025Takeda Expands Partnership with BridGene to Tackle Hard-to-Drug Target...

2/26/2025In Vivo Gene Editing Product ART002 Achieves Saturation of Pharmacolog...

2/26/2025Former NMPA Deputy Commissioner Under Investigation

2/26/2025YolTech Therapeutics Announces Positive Clinical Data for In Vivo Gene...

2/26/2025Hengrui Reports Promising Results for Trastuzumab Rezetecan in HER2-Mu...

2/26/2025Chinese Biotech Firms Cash in on Promising Drug Discoveries via Licens...

2/25/2025XellSmart Secures Second FDA IND Approval for iPSC-Derived ALS Therapy...

2/25/2025Innovent's Dual Immunotherapy for Colon Cancer Advances with NMPA Prio...

2/25/2025Pfizer to Study China-Originated Ivonescimab in ADC Combo Under Summit...

2/25/2025OS Therapies Launches Subsidiary to Seek ADC Joint Ventures in US and ...

2/25/2025China Launches Flagship Hospital Alliance to Advance Integrative Medic...

2/25/2025Ardelyx/Fosun'sTenapanor Approved for Hyperphosphatemia in CKD Dialysi...

2/25/2025BioCity's SC0062 Achieves Primary Endpoint in Phase 2 DKD Trial

2/21/2025FibroGen Sells China Subsidiary to AstraZeneca in $160 Million Deal

2/21/2025China Unveils 2025 Action Plan to Boost Foreign Investment in Biotech ...

Page:11/764 Total number of articles:22895: [First][<<] [9] [10] [11] [12] [13] [>>] [End]